Skip to main content

KADIAN 200 mg Pill: brown, capsule/oblong, 22mm

The pill with imprint KADIAN 200 mg (Brown, Capsule/Oblong, 22mm) has been identified as Morphine Sulfate Extended Release 200 mg and is used for Chronic Pain, Neonatal Abstinence Syndrome, and Pain. It belongs to the drug class Opioids (narcotic analgesics) and is classified as CSA Schedule 2 (High potential for abuse).

Images for KADIAN 200 mg

Morphine sulfate extended release 200 mg KADIAN 200 mg

Morphine Sulfate Extended Release

Imprint
KADIAN 200 mg
Strength
200 mg
Color
Brown
Size
22.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis
National Drug Code (NDC)
00228-3508
Inactive Ingredients
hypromelloses, ethylcellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, diethyl phthalate, magnesium silicate, corn starch, sucrose, gelatin, silicon dioxide, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, ferric oxide yellow, ferric oxide red, shellac, potassium hydroxide, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "KADIAN 200 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.